I Joyeux

687 total citations
9 papers, 568 citations indexed

About

I Joyeux is a scholar working on Immunology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, I Joyeux has authored 9 papers receiving a total of 568 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Immunology, 5 papers in Oncology and 2 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in I Joyeux's work include Immunotherapy and Immune Responses (3 papers), Immune Cell Function and Interaction (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). I Joyeux is often cited by papers focused on Immunotherapy and Immune Responses (3 papers), Immune Cell Function and Interaction (3 papers) and Cancer Immunotherapy and Biomarkers (3 papers). I Joyeux collaborates with scholars based in France, Belgium and Switzerland. I Joyeux's co-authors include Éric Tartour, Wolf H. Fridman, Véronique Mosseri, Claire Mathiot, John Wijdenes, Xavier Sastre‐Garau, François Fossiez, Emmanuel Claret, Virginie Vives and Jacques Banchereau and has published in prestigious journals such as British Journal of Cancer, International Journal of Cancer and European Journal of Immunology.

In The Last Decade

I Joyeux

9 papers receiving 553 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
I Joyeux France	7	406	306	117	46	45	9	568
Sergiusz Markowicz Poland	12	500 1.2×	229 0.7×	233 2.0×	76 1.7×	64 1.4×	30	757
Sigrun Hess Germany	13	515 1.3×	173 0.6×	172 1.5×	34 0.7×	81 1.8×	14	714
Craig S. McCune United States	10	218 0.5×	230 0.8×	104 0.9×	32 0.7×	39 0.9×	16	455
L M Pilarski Canada	8	229 0.6×	126 0.4×	163 1.4×	45 1.0×	23 0.5×	9	494
Giovanna Viale Italy	16	262 0.6×	83 0.3×	132 1.1×	16 0.3×	56 1.2×	24	540
Lieve Coorevits Belgium	12	332 0.8×	125 0.4×	66 0.6×	86 1.9×	73 1.6×	24	554
Lynn Heltemes-Harris United States	15	395 1.0×	179 0.6×	202 1.7×	35 0.8×	19 0.4×	23	695
D. Carbone United States	9	261 0.6×	231 0.8×	230 2.0×	28 0.6×	65 1.4×	15	530
Szilvia Mosolits Sweden	12	334 0.8×	247 0.8×	148 1.3×	24 0.5×	18 0.4×	15	478
Johannes Laengle Austria	12	183 0.5×	227 0.7×	181 1.5×	31 0.7×	45 1.0×	25	505

Countries citing papers authored by I Joyeux

Since Specialization

Citations

This map shows the geographic impact of I Joyeux's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by I Joyeux with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites I Joyeux more than expected).

Fields of papers citing papers by I Joyeux

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by I Joyeux. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by I Joyeux. The network helps show where I Joyeux may publish in the future.

Co-authorship network of co-authors of I Joyeux

This figure shows the co-authorship network connecting the top 25 collaborators of I Joyeux. A scholar is included among the top collaborators of I Joyeux based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with I Joyeux. I Joyeux is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Tartour, Éric, Majid Mehtali, Xavier Sastre‐Garau, et al.. (2000). Phase I clinical trial with IL-2-transfected xenogeneic cells administered in subcutaneous metastatic tumours: clinical and immunological findings. British Journal of Cancer. 83(11). 1454–1461. 19 indexed citations

2.

Tartour, Éric, François Fossiez, I Joyeux, et al.. (1999). Interleukin 17, a T-cell-derived cytokine, promotes tumorigenicity of human cervical tumors in nude mice.. PubMed. 59(15). 3698–704. 247 indexed citations

3.

Tartour, Éric, Pierre van der Bruggen, Valérie Vantomme, et al.. (1998). Major histocompatibility complex class I presentation of exogenous soluble tumor antigen fused to the B-fragment of Shiga toxin. European Journal of Immunology. 28(9). 2726–2737. 67 indexed citations

4.

Tartour, Éric, Pierre van der Bruggen, Valérie Vantomme, et al.. (1998). Major histocompatibility complex class I presentation of exogenous soluble tumor antigen fused to the B-fragment of Shiga toxin. European Journal of Immunology. 28(9). 2726–2737. 1 indexed citations

5.

Montero‐Julian, Félix A., Hervé Brailly, I Joyeux, et al.. (1997). Characterization of soluble gp130 released by melanoma cell lines: A polyvalent antagonist of cytokines from the interleukin 6 family.. PubMed. 3(8). 1443–51. 33 indexed citations

6.

Tartour, Éric, Sylvain Latour, Claire Mathiot, et al.. (1995). Variable expression of CD3‐ζ chain in tumor‐infiltrating lymphocytes (TIL) derived from renal‐cell carcinoma: Relationship with til phenotype and function. International Journal of Cancer. 63(2). 205–212. 92 indexed citations

7.

Tartour, Éric, Thierry Dorval, Véronique Mosseri, et al.. (1994). Serum interleukin 6 and C-reactive protein levels correlate with resistance to IL-2 therapy and poor survival in melanoma patients. British Journal of Cancer. 69(5). 911–913. 98 indexed citations

8.

Thiounn, Nicolas, Claire Mathiot, Éric Tartour, et al.. (1994). Phenotypic and Functional Analysis of Tumour-lnfiltrating Lymphocytes from Patients with Renal Cell Carcinoma. European Urology. 25(2). 151–157. 2 indexed citations

9.

Thiounn, Nicolas, Claire Mathiot, T Flam, et al.. (1994). [CD4 TIL (Tumor Infiltrating Lymphocytes) induce complete response in patients treated with IL-2 (Interleukin-2). Preliminary study].. PubMed. 100(4). 185–8. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact